Menu
Recruiting NCT06420362

Blood Flow Restriction Training in Basketball Players

No phase Interventional Basketball Players

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Blood Flow Restriction.
Who it may be relevant to
Registry conditions: Basketball Players. Basic parameters: 18 years — 25 years · Male.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Examination of the Effect of Exercise Training With Upper Extremity Blood Flow Restriction on Upper Extremity Muscle Strength and Performance in Basketball Players

Overview

Blood Flow Restrictive Exercises (BFR) provide strength increase with less load than required for traditional muscle strengthening and power. As an alternative for populations that have difficulty training with high loads and speeds, low-intensity BFR training has been shown to improve muscle strength and aerobic parameters and to be safe, even in professional athletes and individuals with chronic diseases in various populations. The aim of our study is to examine the effects of BFR applied to the upper extremity on upper extremity muscle strength and performance in basketball players.

Detailed description

Basketball is a demanding sport that requires participants to display a high level of physical fitness and special sporting skills. Basketball requires a high level of anaerobic and aerobic conditioning and is not only a team sport, but also a sport that requires players to demonstrate their individual characteristics. In this regard, it is thought that the determination of performance components based on field tests is a more suitable method for determining the athletic levels of athletes with special needs.

BFR, which aims to restrict blood flow to the muscle during exercise, is traditionally known as 'kaatsu'. Blood flow is restricted with a pressure-controlled and monitorable exercise belt produced for BFR. In order for the method to be successful, the tourniquet method must be applied to the proximal region of the extremity, and in this way, less blood flow to the muscle can actually be achieved.

With BFR, it is recommended that the external pressure be made sufficient to restrict the arterial oxygen pressure between 40% and 80%, and it is thought that the effects of exercise increase in this hypoxic environment. In this way, it is sufficient to perform the exercises at 20% to 40% of the 1 maximum repetition, not 60-85%, which is normally required for muscle hypertrophy. An ischemic and hypoxic muscle environment during BFR; It has been hypothesized that it is produced to cause high levels of metabolic stress and mechanical tension. Both metabolic stress and mechanical tension have been described as "primary hypertrophy factors" and are theorized to activate other mechanisms for muscle growth.

Strength training performed by restricting blood flow plays an important role in muscle hypertrophy by activating the endocrine system. It has been proven that low-intensity blood flow restriction training increases the plasma concentration of growth hormone more than normal exercises. BFR involves low-intensity resistance training and is placed on the proximal portion of the lower or upper extremity muscles to be worked with a bandage or cuff that restricts blood flow, providing appropriate superficial pressure.

The aim of this study is to examine the effects of BFR applied to the upper extremity on upper extremity muscle strength and performance in basketball players.

Interventions

  • Other Blood Flow Restriction
    Before BFR training, a repetition maximal (1-RM) test will be determined by selecting a weight with which athletes can perform a maximum of 10 repetitions. The number of repetitions obtained here and the weight lifted will be written into the Brzycki formula, whose validity and reliability has been proven, and 1-TM will be calculated. Brzycki formula; 1-TM = \[100 x (Weight Lifted) / \[(102.78 - 2.78 x (Number of Reps)\] The arterial occlusion pressure of the participants will be measured with

Primary outcome measures

  • Bench press test [Time frame: Change from Baseline Bench press test at 3 weeks and 6 weeks]
  • Hand Grip Strength [Time frame: Change from Baseline Hand Grip Strength at 3 weeks and 6 weeks]
Secondary outcome measures (4)
  • 20 m Sprint Test [Time frame: Change from Baseline Bench press test at 3 weeks and 6 weeks]
  • T Agility Test [Time frame: Change from Baseline T Agility Test at 3 weeks and 6 weeks]
  • Free Throw Test [Time frame: Change from Baseline Free Throw Test at 3 weeks and 6 weeks]
  • Fatigue Assessment [Time frame: immediately after each BFR session]

Eligibility criteria

Inclusion criteria

  • Being between the ages of 18-25,
  • Having been attending training regularly for at least one year,
  • Having been playing basketball as a licensed player for at least 3 months,
  • Male athletes,
  • Volunteering to participate in the study

Exclusion criteria

  • Individuals with orthopedic or neurological disabilities that may prevent the exercise test,
  • Individuals who have had a sports injury in the last 6 months,
  • Not actively participating in training,
  • Taking a break from sports
  • Individuals with inadequate cooperation

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Crossover
Masking
Single blind
Primary purpose
Treatment

Study locations

Turkey (Türkiye) · 1 center
  • Biruni University — Istanbul

Identifiers

NCT: NCT06420362 · 80-23-05

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗